Sep . 28, 2025 15:25 Back to list
The Cowingene HPV 28 Genotyping Detection Kit (Liquid) represents a significant advancement in molecular diagnostics for Human Papillomavirus (HPV). Developed by Taizhou Cowingene Biotech Co., Ltd., this kit leverages cutting-edge PCR technology to detect 28 HPV genotypes, including high-risk strains such as 16, 18, 31, and 33. This article provides an in-depth analysis of the product's features, advantages, technical specifications, applications, and the company's commitment to innovation in diagnostic solutions.
Image: Read More About hpv detection by pcr
Human Papillomavirus (HPV) is the most common sexually transmitted infection, with over 200 identified genotypes. While many infections are harmless, certain high-risk HPV types are strongly associated with cervical cancer, the second most common cancer in women globally. Taizhou Cowingene Biotech Co., Ltd. recognizes the critical need for accurate and comprehensive HPV detection to enable early intervention and personalized treatment strategies.
Traditional HPV testing methods often focus on high-risk genotypes, but the Cowingene HPV 28 Genotyping Detection Kit expands this scope by identifying 28 distinct HPV genotypes, including both high-risk and low-risk strains. This broader coverage allows for a more nuanced understanding of HPV infection patterns and risk stratification.
Image: Read More About human papillomavirus pcr
The Cowingene HPV 28 Genotyping Detection Kit is engineered to deliver exceptional performance, reliability, and user-friendliness. Below are its core features and advantages:
The kit detects 28 HPV genotypes, including 16, 18, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 55, 56, 58, 59, 61, 66, 68, 73, 81, 82, 83, and 26. This extensive coverage ensures that both high-risk and low-risk strains are identified, providing clinicians with actionable data for patient management.
Utilizing polymerase chain reaction (PCR) technology, the kit achieves high sensitivity and specificity, minimizing false-negative and false-positive results. This precision is critical for early detection of HPV infections, which is essential for preventing cervical cancer progression.
The kit is validated for use with multiple specimen types, including cervical swabs, urine, and self-collected vaginal samples. This flexibility enhances accessibility, particularly in resource-limited settings where traditional sampling methods may be challenging.
The detection process is streamlined to reduce hands-on time and increase throughput. The kit's optimized protocols ensure consistent results, making it ideal for high-volume diagnostic laboratories.
Image: Read More About human papilloma virus hpv pcr
| Parameter | Details |
|---|---|
| Target Genotypes | 28 HPV genotypes (16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 55, 56, 58, 59, 61, 66, 68, 73, 81, 82, 83) |
| Sample Types | Cervical swab, Urine, Self-collected vaginal |
| Technology | PCR-based genotyping |
| Limit of Detection (LOD) | 100 copies/mL (varies by genotype) |
| Throughput | Up to 96 samples per run |
| Turnaround Time | Less than 4 hours |
| Storage Conditions | -20°C for reagents; 2–8°C for stabilized samples |
The Cowingene HPV 28 Genotyping Detection Kit is a versatile tool with applications across various healthcare domains:
By identifying high-risk HPV genotypes, the kit plays a pivotal role in cervical cancer screening programs. Early detection of persistent infections with high-risk HPV types enables timely intervention, such as colposcopy or treatment, significantly reducing cancer incidence and mortality.
The kit's comprehensive genotype coverage makes it an invaluable resource for researchers studying HPV prevalence, transmission dynamics, and the effectiveness of vaccination programs. Its ability to analyze multiple genotypes simultaneously supports large-scale epidemiological studies.
With its compatibility with self-collected vaginal samples, the kit facilitates decentralized testing, allowing individuals to collect samples at home and send them to laboratories. This approach increases screening accessibility, particularly in underserved communities.
Taizhou Cowingene Biotech Co., Ltd. is a leading biotechnology company based in Taizhou, China, dedicated to developing innovative diagnostic solutions for infectious diseases and genetic disorders. With a strong focus on research and development, the company has established itself as a trusted provider of high-quality molecular diagnostic products.
Founded on the principles of scientific excellence and patient-centric innovation, Cowingene has consistently delivered products that meet global standards. The HPV 28 Genotyping Detection Kit exemplifies the company's commitment to advancing healthcare through precision diagnostics.
The Cowingene HPV 28 Genotyping Detection Kit aligns with the rigorous standards set by the National Institute of Standards and Technology (NIST), a U.S. government agency that develops and promotes measurement standards. While the kit itself is not a NIST product, its design and validation processes reflect the importance of metrological accuracy in diagnostic technologies.
NIST's work in establishing standards for molecular diagnostics, such as standard reference materials (SRMs), underscores the critical role of precision in healthcare. By adhering to such principles, Cowingene ensures its products meet the highest levels of reliability and consistency.
The Cowingene HPV 28 Genotyping Detection Kit (Liquid) is a testament to the power of innovation in molecular diagnostics. With its comprehensive genotype coverage, high accuracy, and versatility, this kit addresses critical needs in HPV detection and cancer prevention. Taizhou Cowingene Biotech Co., Ltd. continues to drive advancements in healthcare, ensuring that diagnostic tools like this one contribute to improved patient outcomes worldwide.
National Institute of Standards and Technology (NIST). (n.d.). What We Do. Retrieved from https://www.nist.gov/
Standard Reference Materials for Molecular Diagnostics. (n.d.). Retrieved from https://www.nist.gov/publications/standard-reference-materials-for-molecular-diagnostics
Related PRODUCTS
Understanding Monkeypox Testing PCR – Global Health & Diagnostic Insights
NewsNov.24,2025Comprehensive Guide to Monkey Pox Detection: Methods, Applications & Innovations
NewsNov.23,2025Essential Guide to Monkeypox Detection: Technologies, Applications & Future Trends
NewsNov.23,2025Understanding Strep B Test Cost: Global Insights and Healthcare Impact
NewsNov.22,2025Group B Strep DNA Test – Fast, Accurate Screening to Prevent Neonatal Infection
NewsNov.21,2025Essential Guide to Group B Strep Test Kits: Benefits, Uses & Innovations
NewsNov.20,2025